NEW STUDIES     ONGOING STUDIES  

The Step Study (HVTN 502/Merck 023): A Phase II HIV Vaccine Study
This is a Phase II Proof of Concept study of an experimental vaccine that may one day prevent HIV infection or keep people who do become HIV infected healthier. Volunteers cannot become HIV infected or get AIDS by receiving this vaccine.

This study is to find out if a group intervention can lower sexual risk of gay and bi men who use alcohol or drugs. It’s open to men who are positive or negative for HIV.

Phase I Vaccine Trial
Phase I trials evaluate the safety, tolerability, and immunogenicity of a preventive HIV vaccine in adults.

UNITY
An intervention studying the efficacy of enhanced HIV counseling and HIV vaccine education with substance using women.

HIGHLIGHTS NEWS AND EVENTS WORKSHOPS


HIV Vaccine Awareness Event
View Photos


Vaccine-O-licious II
May 16th, 2007
Learn More

HIV Microbicides 101
Learn about where we are in the search for a safe and
effective HIV microbicide...
Learn More

Project Achieve's research and community education work is funded through grants received from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)

Content last upadated 7/5/06. Website and contents copyrighted through September 2009©.
All rights reserved. Web site designed by JSW Media & Communications

PROJECT ACHIEVE LOCATIONS

Bronx Site
391 East 149th Street,
Suite 405
Bronx, NY 10455
718-402-0743 tel
718-402-9874 fax

Union Square Site
853 Broadway,
Suite #1111
New York, NY 10003
212-388-0008 tel

212-475-5208 fax



View Images and stories from our "Why Not You" exhibit.

Click Here
The NYC HIV VACCINE Trials Unit is looking for
a substance that will
teach the body’s immune
system to recognize and
protect itself against HIV.


Learn More About VTU